GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DT&CRO Co Ltd (XKRX:383930) » Definitions » Other Income (Expense)

DT&CRO Co (XKRX:383930) Other Income (Expense) : ₩-5,284 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is DT&CRO Co Other Income (Expense)?

DT&CRO Co's other income expense for the DT&CRO Co's pretax income for the three months ended in Mar. 2024 was ₩89 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-5,284 Mil.

DT&CRO Co Other Income (Expense) Historical Data

The historical data trend for DT&CRO Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DT&CRO Co Other Income (Expense) Chart

DT&CRO Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
-1,674.34 -444.78 44.37 -5,315.81

DT&CRO Co Quarterly Data
Jun21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only 56.24 25.35 20.86 -5,418.27 88.55

DT&CRO Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-5,284 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DT&CRO Co  (XKRX:383930) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

DT&CRO Co (XKRX:383930) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DT&CRO Co Ltd (XKRX:383930) » Definitions » Other Income (Expense)
Comparable Companies
XKRX:298060 XKRX:065650 XKRX:299660 XKRX:142760 XKRX:115180 XKRX:032790 XKRX:222110 XKRX:036480 XKRX:456570 XKRX:208340 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
28, Baengnyeong-ro 20beon-gil, 2nd, 3rd, 4th floor, Na-dong, Cheoin-gu, Gyeonggi-do (Yubang-dong), Yongin-si, KOR, 17042
Website
http://www.dtncro.com
DT&CRO Co Ltd conducts a series of consigned research, from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics and medical devices, to analysis, bioactivity, clinical trials, and licensing consulting. provided as a service.

DT&CRO Co (XKRX:383930) Headlines

No Headlines